Firmes privées et gouvernance mondiale de la santé
Private companies and global health governance
Since the end of the 1990s, multinational firms — mainly pharmaceutical companies — have been very active in the global health sector. Now, these same firms have formed numerous international public-private partnerships. What is the role of these partnerships and what actions do they implement? Are they capable of co-operating with States, NGOs, international organisations and private foundations?
Focusing on the fight against HIV/AIDS, tuberculosis, malaria and neglected tropical diseases — issues that originally prompted international co-operation — this book charts the introduction of companies into global health governance via institutional organisations and market co-operation mechanisms. The author shows that this has been a gradual process through which these companies, which were originally autonomous actors, have become subject to regulations and ultimately transformed into governance partners.
This volume provides a unique look at the participation of economic multilateral actors and their ability to alter the functioning of global health governance.